Efficacy and Safety Study of rTMS for Upper Extremity Motor Function Recovery in Ischemic Stroke Patients
TAMAS
A Randomized, Double-Blind, Sham-Controlled, Multi-center Clinical Trial to Evaluate Efficacy and Safety of rTMS 『TMS』 for Upper Extremity Motor Function Recovery in Patients With Ischemic Stroke
1 other identifier
interventional
77
1 country
3
Brief Summary
The purpose of this study is to Evaluate Efficacy and Safety of rTMS 『TMS』 for Upper Extremity Motor Function Recovery in Patients with Ischemic Stroke
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Apr 2014
Longer than P75 for not_applicable stroke
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2014
CompletedFirst Posted
Study publicly available on registry
March 7, 2014
CompletedStudy Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2018
CompletedSeptember 9, 2020
September 1, 2020
3.8 years
March 6, 2014
September 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Box and Block Test (affected hand)
Before rTMS (baseline) and 10 days after the completion of 10 sessions of rTMS
up to 17 days
Secondary Outcomes (8)
Box and Block Test (Affected and unaffected hand)
up to 40 days
Barthel Index
up to 40 days
National Institutes of Health Stroke Scale
up to 40 days
Fugl-Meyer Assessment Scale
up to 40 days
Grip strength (hand grip, pinch grip, lateral prehension, three jaw chuck)
up to 40 days
- +3 more secondary outcomes
Other Outcomes (1)
Vital Sign
up to 40 days
Study Arms (2)
true coil
EXPERIMENTALUse the true coil / Low frequency rTMS / Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp
sham coil
SHAM COMPARATORUse the sham coil / Low frequency rTMS / Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: vertical to scalp
Interventions
Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp
Eligibility Criteria
You may qualify if:
- yrs old
- Radiologically confirmed ischemic stroke within 90 days
- Brunnström stage 3-5 in the affected hand (ischemic stroke-induced hemiplegic side)
- Patients received stroke treatment and on secondary prevention medication
- Written informed consent
You may not qualify if:
- Previous medical histories of stroke, cerebral vascular operation, seizure
- Pregnancy, Breastfeeding
- Patients with hemorrhagic stroke, traumatic brain injury
- Skin lesion in the stimulation site of scalp
- Metal implants in the body (cardiac pacemaker or aneurysm clip)
- Unable to have regular physical and occupational therapies on the affected hand
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Bundang Hospitallead
- DongGuk Universitycollaborator
- Seoul National University Hospitalcollaborator
- REMEDcollaborator
Study Sites (3)
DongGuk University Ilsan Hospital
Goyang-si, Gyeonggi-do, 410-773, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Seoul National University Hospital
Seoul, 110-744, South Korea
Related Publications (1)
Kim WS, Kwon BS, Seo HG, Park J, Paik NJ. Low-Frequency Repetitive Transcranial Magnetic Stimulation Over Contralesional Motor Cortex for Motor Recovery in Subacute Ischemic Stroke: A Randomized Sham-Controlled Trial. Neurorehabil Neural Repair. 2020 Sep;34(9):856-867. doi: 10.1177/1545968320948610. Epub 2020 Aug 18.
PMID: 32807013DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nam-Jong Paik, MD, PhD
Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 6, 2014
First Posted
March 7, 2014
Study Start
April 1, 2014
Primary Completion
January 23, 2018
Study Completion
February 28, 2018
Last Updated
September 9, 2020
Record last verified: 2020-09